Meeting Archive

2014 Calendar

Global Laboratory Initiative

Meeting on high-priority target product profiles for new TB diagnostics
Geneva, Switzerland
28 - 29 April 2014

• Meeting report

6th GLI Partners' Meeting
Executive Board Meeting Room, WHO, Geneva
30th April - 2nd May 2014

• Agenda and presentations
• Xpert Implementers Global Forum meeting report
• List of Participants
• Nomination of the NRL Copenhagen as WHO/GLI TB Supranational Reference Laboratory
• Nomination of the NITRD New Delhi as National Centre of Excellence and part of WHO/GLI TB Supranational Reference Laboratory network
• Nomination of Aga Khan University in Karachi as WHO/GLI TB Supranational Reference Laboratory
• 3 nominated members of the SRL network

2013 Calendar

5th Annual GLI Partners’ Meeting

Les Pensières, Veyrie-du-Lac, France
15-18 April 2013

• Announcement
• Agenda and Presentations
• List of participants
• Speech of Mario Raviglione
• Nomination of the NTRL Uganda as WHO/GLI TB Supranational Reference Laboratory
• Group photo

2012 Calendar

1st International Conference of the African Society for Laboratory Medicine (ASLM)

Accurate Laboratory Diagnostics - A Pillar of Quality Healthcare
Cape Town International Convention Centre, South Africa
4-7 December 2012
For more information, click here

1st International Forum on Diagnostics (IFDIAG)

Les Pensières Conference Centre, Annecy, French Alps
2-9 September 2012
For more information, click on http://www.fondation-merieux.org/

4th Annual GLI Meeting/Consultation of the SRL network/Early implementers meeting on Xpert MTB/RIF roll out

Les Pensières, Veyrier-du-Lac, France
17-19 April 2012
Agenda and presentations
List of Participants

WHO Expert Group Meeting (WHO-EGM): Policy guidance on the use of Loop-mediated Isothermal Amplification (LAMP) assay for detection of tuberculosis

WHO Geneva, Switzerland
20 April 2012

Expert Group Meeting report

WHO Expert Group Meeting (WHO-EGM): Policy Guidance on anti-tuberculosis drug susceptibility testing

WHO Geneva, Switzerland
19-20 March 2012

WHO Expert Group Meeting (WHO-EGM): Policy Guidance on Hain MTBDRsl second-line drug molecular line probe assays

WHO Geneva, Switzerland
21 March 2012

Expert Group Meeting report

2011 Calendar

Update on the implementation and roll out of the Xpert MTB/RIF

Implementation and roll-out of the Xpert MTB/RIF system for rapid diagnosis of tuberculosis and multidrug-resistance: Workshop for Early Implementers

Consultation: Impact of WHO-endorsed molecular diagnostics on TB and MDR-TB case- and treatment outcome definitions

Meeting on Lab Accreditation

Geneva, 6 - 7 July
Agenda

Day 1

• AFRO PRESENTATION TB GLI MEETING ON ACCREDIT_AA [.pdf]
• Cognat GLI July 2011_Cognat [.pdf]
• Datema 110706_Geneva_v0.3 [.pdf]
• Fine Glen Accred overview ppt 06 July 2011 [.pdf]
• Klatser 20110706 GLI Geneva Paul Klatser [.pdf]
• Peart WHOPres1 (Bambi) [.pdf]
• Ridderhof GLI accreditation July2013 Ridderhof [.pdf]
• Shinnick_Comparison_2011_final [.pdf]
• Twell GLI Consult 6_7July2011JT [.pdf]

Day 2

• Biosafety Jeju 2010 [.pdf]
• Engelberts 20110706 NTRL Uganda GLI Geneva [.pdf]
• Oskam 110707 GLI meeting presentation [.pdf]

Review of Global Laboratory Initiative (GLI) and World Health Organization (WHO) tools and guidance for laboratory strengthening

WHO Geneva, Switzerland
22-24 August 2011

Agenda, List of Participants

2010 Calendar

Use of commercial serological tests for the diagnosis of TB

Date and time: 22 July 2010, 09:00 - 1600
Venue: Salle B, WHO-HQ Main Building, Geneva, Switzerland
Agenda
Meeting report
Policy statement on use of commercial serological tests for the diagnosis of TB

Use of Interferon - Gamma Release Assays (IGRAs) in TB control in low and middle-income settings

Date and time: 20-21 July 2010, 09:00 - 18:00
Venue: WHO-HQ, Geneva, Switzerland
Agenda
Meeting report
Policy statement on use of Interferon - Gamma Release Assays (IGRAs) in TB control in low and middle-income settings

GLOBAL CONSULTATION ON THE IMPLEMENTATION AND SCALE-UP OF THE "GeneXpert MTB/RIF System" FOR RAPID DIAGNOSIS OF TB AND MDR-TB

Date and time: 30 November -02 December 2010, 09:00 - 18:00
Venue: Centre International de Conférences de Genève (CICG)
17, Rue Varembé, Geneva, Switzerland
Agenda

Presentations

Day 1

session 1

• Meeting scope and objectives K Weyer [.pdf]
• New frontiers changing diagnostic paradigms G Roscigno [.pdf]
• Responding to change Rapid policy development by WHO M Raviglione K Weyer [.pdf]

session 2

• Xpert MTB RIF - development and analytical performance M Perkins [.pdf]
• Xpert MTB RIF - evidence and operational considerations C Boehme [.pdf]
• Xpert MTB RIF - update on price negotiations and market dynamics G Roscigno [.pdf]

session 3

• An ethical dillemma - diagnosis without treatment A Reis [.pdf]
• From diagnosis to treatment and care - the missing links P Nunn [.pdf]
• Xpert MTB RIF - opportunity to enhance private sector engagement M Uplekar [.pdf]
• Xpert MTB RIF - scenarios for cost effectiveness A Vassall [.pdf]
• Xpert MTB RIF in the Global plan 2011-2015 - what it will cost K Floyd [.pdf]

session 4

• Civil society perspective F Varaine [.pdf]
• Civil society perspective J Syed [.pdf]
• Pateint Perspectives on GeneXpert L Chesire N Otwoma [.pdf]
• Use of Xpert MTB RIF in the private sector - Pakistan A Khan [.pdf]

session 5

• Global Consultation Algorithm Xpert DOTS Expansion [.pdf]
• Global Consultation Algorithm Xpert TBHIV [.pdf]
• Global Consultation Xpert Algorithm MDR-TB [.pdf]

Day 2

• Discussion on diagnostic algorithm with Xpert DOTS Expansion [.pdf]
• Discussion on diagnostic algorithm with Xpert MDR-TB [.pdf]
• Discussion on diagnostic algorithm with Xpert TB HIV [.pdf]

Day 3

• Country plan for scaling up Xpert MTB-RIF G Coetzee [.pdf]
• Final diagnostic algorithm with Xpert MDR D Falzon [.pdf]
• Final diagnostic algorithm with Xpert DOTS Expansion S Sahu [.pdf]
• Final diagnostic algorithm with XpertTB HIV D Sculier [.pdf]
• Global Roadmap for scaling up Xpert MTB-RIF K Weyer [.pdf]
• Increasing access to vulnerable groups through TB REACH L Ditiu [.pdf]
• Learning by doing through EXPAND-TB E Adam [.pdf]
• Mobilising country capacity through TB CARE A Piatek [.pdf]
• Targeting HIV settings through PEPFAR B Coggin [.pdf]
• Xpert_TBHIV_ambulatory_02 12 10_v1 [.pdf]
• Xpert_TBHIV_seriously ill_02 12 01_v1doc [.pdf]

Creating Partnerships for Innovation in Tuberculosis Diagnostics and Laboratory Services:

3rd Global Laboratory Initiative (GLI) Meeting Jointly organised by World Health Organization & Fondation Mérieux
Date and time: 04 -05 October 2010, 09:00 - 18:00
Venue: Les Pensières, Veyrier-du-Lac, France
Agenda

Presentations

Lundi

• Expand TB for 3rd GLI meeting [.pdf]
• Fuad Expand TB for 3rd GLI meeting [.pdf]
• GLI 2010 WEYER [.pdf]
• GLI annecy 2010 [.pdf]
• GLI Priorties Annecy 04OCT10 [.pdf]
• Integration slidesGLI Annecy Oct 2010 [.pdf]
• Mundy,C-GLI Presentation - Lab Tools Package 4 Oct 10 [.pdf]
• TB DxTics Pipeline GLI Annecy 04OCT10 [.pdf]
• TB REACH GLI ppt Oct 10 [.pdf]

Mardi

• 101005 DTLab and GLI [.pdf]
• 20101004 GLI PaulKlatser [.pdf]
• GLI accreditation smear networks [.pdf]
• Hakiruwizera - GLI 1- Annecy Oct 2010.JT [.pdf]
• IOM Laboratory services for 3rd GLI meeting Oct'10 [.pdf]
• Lab Information - LIPHE - Oct 5 2010 -- final [.pdf]
• Pawan Ventilation workstationOct 05 [.pdf]
• SRLN_Annecy_2010 [.pdf]
• UnionLab2010 [.pdf]
• USAID_GLI_Oct_2010 [.pdf]

GLOBAL CONSULTATION OF THE WHO-GLI TB SUPRANATIONAL REFERENCE LABORATORY NETWORK

Date and time: 14-15 April 2010, 09:00 - 18:00
Venue: Main Building room A, WHO Geneva, Switzerland
Agenda
Meeting Report
TOR
Eligibility Criteria

Presentations

• 00 - Current WHO Policy Update [.pdf]
• 01 - Current draft WHO-CDC Biosafety recommendations [.pdf]
• 02 - GLaDMap Global Laboratory Database [.pdf]
• 03 - Overview of SRLN efforts [.pdf]
• 04 - WHO AFRO Regional Perspective [.pdf]
• 05 - WHO EMRO Regional Perspective [.pdf]
• 06 - WHO SEARO Regional Perspective [.pdf]
• 07 - WHO WPRO Regional Perspective [.pdf]
• 08 - WHO PAHO Regional Perspective [.pdf]
• 09 - GLI Roadmap [.pdf]
• 10 - Optimizing the SRLN in Africa [.pdf]
• 11 - Eligibility criteria [.pdf]
• 12 - SRL accreditation - What is needed [.pdf]
• 13 - Summary Day 1 [.pdf]
• 14 - Creation of formal links with SRL and NRL [.pdf]
• 15 - ExpandTB Project [.pdf]
• 16 - SRL TA for DRS [.pdf]
• 17 - ERLN for Tuberculosis European [.pdf]
• 18 - Donor perspectives on SRLN funding (Governmental) [.pdf]
• 19 - Donor perspective Eli Lilly [.pdf]
• 20 - Conclusion and Next steps [.pdf]
• 21 - Proposed TORs for the SRLN [.pdf]

GLI Consultants Workshop

To support TB laboratory strengthening efforts in Global Fund round 10 proposals preparation
Dates: 12th-16th July 2010
Venue: Room HTM65 D Building WHO Geneva, Switzerland
Background and Objectives
Agenda

2009 Calendar

2nd Annual GLI Meeting jointly organized by WHO and Fondation Mérieux:

Agenda

Presentations

• Microsoft PowerPoint - Armand VAN DEUN [.pdf]
• Microsoft PowerPoint - Gavin MACGREGOR SKINNER [.pdf]
• Microsoft PowerPoint - Jessica MINION [.pdf]
• Microsoft PowerPoint - JF de LAVISON [.pdf]
• Microsoft PowerPoint - John NKENGASONG 2 [.pdf]
• Microsoft PowerPoint - John NKENGASONG [.pdf]
• Microsoft PowerPoint - John RIDDERHOF [.pdf]
• Microsoft PowerPoint - Karen STEINGART [.pdf]
• Microsoft PowerPoint - Karin WEYER [.pdf]
• Microsoft PowerPoint - Keith KLUGMAN [.pdf]
• Microsoft PowerPoint - Kitty LAMBREGTS [.pdf]
• Microsoft PowerPoint - Linda OSKAM [.pdf]
• Microsoft PowerPoint - Lucia BARRERA [.pdf]
• Microsoft PowerPoint - Maarten VAN CLEEFF [.pdf]
• Microsoft PowerPoint - Mario RAVIGLIONE [.pdf]
• Microsoft PowerPoint - Mark PERKINS [.pdf]
• Microsoft PowerPoint - Paul KLASTER [.pdf]
• Microsoft PowerPoint - Paul NUNN [.pdf]
• Microsoft PowerPoint - Thomas SHINNICK [.pdf]

NON-COMMERCIAL CULTURE METHODS AND MYCOBACTERIOPHAGE-BASED ASSAYS FOR RAPID SCREENING OF PATIENTS AT RISK OF DRUG-RESISTANT TUBERCULOSIS

Date and time: 08 - 09 September 2009, 09:00 - 18:00
Venue: Crowne Plaza Hotel, Geneva, Switzerland
Agenda
Meeting Report
Policy statement on non-commercial culture and drug-susceptibility testing methods for screening patients at risk for MDR-TB

APPROACHES TO IMPROVE SPUTUM SMEAR MICROSCOPY FOR TUBERCULOSIS DIAGNOSIS

Date and time: 07 September 2009, 08:30 - 18:00
Venue: Crowne Plaza Hotel, Geneva, Switzerland
Agenda
Meeting Report
Policy statement on same-day diagnosis of tuberculosis by microscopy
Policy statement on Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis

WHO Expert Group Meeting (WHO-EGM): Guidance on Biosafety related to TB laboratory diagnostic procedures

WHO Geneva, Switzerland
08-09 April 2009

Agenda, List of Participants, Meeting Report